Works matching IS 20953941 AND DT 2022 AND VI 19 AND IP 5
Results: 15
The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 755, doi. 10.20892/j.issn.2095-3941.2020.0800
- By:
- Publication type:
- Article
Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 742, doi. 10.20892/j.issn.2095-3941.2021.0529
- By:
- Publication type:
- Article
Improved diagnosis of thyroid cancer aided with deep learning applied to sonographic text reports: a retrospective, multi-cohort, diagnostic study.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 733, doi. 10.20892/j.issn.2095-3941.2020.0509
- By:
- Publication type:
- Article
Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 707, doi. 10.20892/j.issn.2095-3941.2021.0190
- By:
- Publication type:
- Article
The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 619, doi. 10.20892/j.issn.2095-3941.2021.0058
- By:
- Publication type:
- Article
Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 685, doi. 10.20892/j.issn.2095-3941.2020.0728
- By:
- Publication type:
- Article
Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/BRAF/TAK1/ERK/ETV4 signaling.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 669, doi. 10.20892/j.issn.2095-3941.2021.0137
- By:
- Publication type:
- Article
JaponiconeA induces apoptosis of bortezomib-sensitive and -resistant myeloma cells in vitro and in vivo by targeting IKKβ.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 651, doi. 10.20892/j.issn.2095-3941.2020.0473
- By:
- Publication type:
- Article
Akt isoforms differentially provide for chemoresistance in prostate cancer.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 635, doi. 10.20892/j.issn.2095-3941.2020.0747
- By:
- Publication type:
- Article
Effects of population aging on the mortality burden of related cancers in urban and rural areas of China, 2004-2017: a population-based study.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 696, doi. 10.20892/j.issn.2095-3941.2021.0538
- By:
- Publication type:
- Article
Immunology and immunotherapy in breast cancer.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 609, doi. 10.20892/j.issn.2095-3941.2021.0597
- By:
- Publication type:
- Article
Targeting the COP9 signalosome for cancer therapy.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 573, doi. 10.20892/j.issn.2095-3941.2021.0605
- By:
- Publication type:
- Article
Therapeutic revolution for inoperable stage III non-small cell lung cancer in the immune era.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 569, doi. 10.20892/j.issn.2095-3941.2022.0254
- By:
- Publication type:
- Article
PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 565, doi. 10.20892/j.issn.2095-3941.2022.0244
- By:
- Publication type:
- Article
Advances in lung cancer screening and early detection.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 5, p. 591, doi. 10.20892/j.issn.2095-3941.2021.0690
- By:
- Publication type:
- Article